60295-52-5

Basic information

• Product Name: TERT-BUTYL 2-(TERT-BUTYL)-1-HYDRAZINECARBOXYLATE
• Synonyms: TERT-BUTYL 2-(TERT-BUTYL)-1-HYDRAZINECARBOXYLATE;Hydrazinecarboxylic acid, 2-(1,1-dimethylethyl)-, 1,1-dimethylethyl ester;N'-tert-butyl(tert-butoxy)carbohydrazide
• CAS NO: 60295-52-5
• Molecular Formula: C₉H₂₀N₂O₂
• Molecular Weight: 188.27
• Mol File: 60295-52-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: TERT-BUTYL 2-(TERT-BUTYL)-1-HYDRAZINECARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 2-(TERT-BUTYL)-1-HYDRAZINECARBOXYLATE(60295-52-5)
• EPA Substance Registry System: TERT-BUTYL 2-(TERT-BUTYL)-1-HYDRAZINECARBOXYLATE(60295-52-5)

Safety Data

• Hazardous Substances Data: 60295-52-5(Hazardous Substances Data)

Usage

General Description

TERT-BUTYL 2-(TERT-BUTYL)-1-HYDRAZINECARBOXYLATE is a chemical compound with the molecular formula C10H20N2O2. It is a hydrazine derivative that is commonly used in organic synthesis as a reagent for introducing hydrazine functionality into molecules. TERT-BUTYL 2-(TERT-BUTYL)-1-HYDRAZINECARBOXYLATE is also used in pharmaceutical and agrochemical industries for the synthesis of various bioactive compounds. It is a colorless liquid with a slightly pungent odor and is considered to be moderately toxic and flammable. TERT-BUTYL 2-(TERT-BUTYL)-1-HYDRAZINECARBOXYLATE is handled and used with caution due to its potential health and safety hazards.

Upstream product

• 105838-14-0 tert-butyl N-tosyloxycarbamate 
• 75-64-9 tert-butylamine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 36016-38-3 tert-Butyl N-hydroxycarbamate 
• 7400-27-3 tertbutylhydrazine hydrochloride 
• 32064-67-8 tert-butylhydrazine 
• 507-40-4 tert-butylhypochlorite 
• 1118-12-3 1,1-dimethylethylurea 

Downstream Products

• 162752-59-2 N-(3,5-Dimethylbenzoyl)-N-tert-Butyl-Hydrazine 
• 32064-67-8 tert-butylhydrazine 

Relevant articles and documents

TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS

The present disclosure is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, as mPGES-1 inhibitors. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful in the treatment of pain and/or inflammation from a variety of diseases or conditions, such as asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases.

AZA-TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS

The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Six-membered heterocyclic derivatives of N'-substituted N,N'-diacylhydrazines

This invention relates to insecticidal compositions containing six-membered heterocyclic derivatives of N'-substituted-N,N'-diacylhydrazines, methods of using such compositions and novel six-membered heterocyclic derivatives of N'-substituted-N,N'-diacylhydrazines.